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Abstract 
Purpose: To determine the prevalence of Epstein Barr Virus (EBV) in oral hairy leukoplakia lesions (OHL) in 
HIV+ Venezuelan patients. Material and Method: In this case study, we evaluated 21 HIV+ adult patients with 
clinically present OHL lesions, 11 who were undergoing antiretroviral therapy, 10 who were not undergoing 
therapy and 10 HIV-negative adult patients with hyperkeratotic oral mucosal lesions. All of the subjects were as-
sessed at the Infectious Disease Center, Faculty of Dentistry, Central University of Venezuela, and were clinically 
examined to detect oral mucosal lesions with the confirmed histopathologic diagnosis. Nested-PCR was used to 
determine the EBV infection and the latent membrane protein-1 (LMP-1) expression by immunohistochemistry. 
Results: Of the subjects, 16/21 (76%) of the HIV+/AIDS patients tested positive for EBV, whereas 5/10 (50%) of 
the HIV-negative subjects tested positive for EBV. Conclusions: In the present study, a higher EBV prevalence was 
observed in HIV-positive patients when compared to HIV-negative patients without oral hairy leukoplakia, con-
firming the etiologic role in this entity. The LMP-1 in OHL patients who were both HIV+ and EBV+ was highly 
expressed (60%) at the epithelial basal cells. No association between the alcohol and tobacco consumption was 
observed among the EBV-positive cases.
Key words: Oral hairy leukoplakia, human immunodeficiency virus, Epstein Barr virus, latent membrane pro-
tein. 
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Introduction
The oral lesions associated to human immunodeficiency 
virus infection represent an important problem in the 
HIV+ population, being predictive of the disease pro-
gression (1). Several studies have been done to establish 
the prevalence of the oral lesions associated to the dis-
ease, related with age, gender, tobacco, CD4 cell count 
and viral load (2,3).
Preliminary investigations conducted in Venezuela (4) 
demonstrated that oral candidiasis was the most fre-
quent opportunistic infection, followed by oral hairy 
leukoplakia and melanic hiperpigmentation, observing 
a high viral load associated to these oral lesions pres-
ence but independently of the CD4+ count. 
Oral hairy leukoplakia (OHL) is related to EBV infec-
tion characterized by a viral replication within the epi-
thelium of the lateral border of the tongue (5). Clinically 
presents as a white oral lesion and has been considered 
as an early indicator of HIV infection as well as a pro-
gression marker of the disease. Therefore, it of outmost 
importance to establish an early diagnosis. 
OHL has been mainly related to severe immunodefi-
ciency similar to the HIV infection, malignant tumors 
and organ transplanted patients (7). However, OHL has 
also been reported in patients with moderate or minor 
immunodeficiency and immunocompetent individuals 
(8).
EBV is a member of the Herpesviridae family, gam-
maherpesviridae subfamily infecting lymphocytes and 
epithelial cells. Previous EBV seroprevalence studies 
have indicated that more than 90% of the world popula-
tion has antibodies against EBV, being the etiologic fac-
tor in malignant diseases such as Burkitt s´ Lymphoma 
and Nasopharyngeal carcinoma, mainly characterized 
by EBV latent infection and cellular proliferation (5). 
The clinical and histopathologic OHL features are not 
enough for the final diagnosis, the EBV presence is re-
quired to fulfill the diagnostic definitive criteria (9). The 
virus could be detected by LMP-1 expression using im-
munohistochemistry or using Nested PCR detecting the 
viral DNA (10).
The latent membrane protein 1 (LMP-1) is considered 
the principal EBV oncoprotein, its expression is re-
quired for the EBV latent infection and B cell transfor-
mation (10). 
With the antiretroviral therapy use in HIV/AIDS, the 
opportunistic infections have declined due to the use of 
antiretroviral therapy leading to a better quality of pa-
tient life (11). 
The aim of the present study was to determine the prev-
alence of Epstein Barr virus (EBV) in oral hairy leuko-
plakia lesions (OHL) in HIV+ venezuelan patients.
Materials and Methods
We evaluated in this cases study, 21 HIV+ adult patients 
with clinically present OHL lesions, 11 with antiretro-
viral therapy, 10 without therapy and 10 HIV negative 
adult patients with hiperkeratotic oral mucosal lesions. 
All of them were assessed at the Infectious Disease 
Center, Faculty of Dentistry, Central University of 
Venezuela and clinically examined to detect oral mu-
cosal lesions present and establish the histopathologic 
diagnosis. Nested-PCR was used to determine the EBV 
infection and the LMP-1 expression by immunohisto-
chemistry. In the present study, patiens with white oral 
lesions previously diagnosed as oral lichen planus were 
excluded.
Clinical evaluation was conducted by the same exam-
iner, an oral medicine practitioner following the Clear-
inghouse criteria of diagnosis (12) data was collected in 
a chart designed for this purpose. All the included pa-
tients with clinically present oral white lesions followed 
the diagnostic criteria reported by Axell et al. (13) and 
all signed a written informed consent to participate in 
the study.
Incisional biopsies were taken from patients with oral 
lesions divided in two fragments, one for the histopatho-
logic and immunohistochemical diagnosis and the other 
one was frozen in -70°C for the molecular analysis by 
nested PCR. Prior to DNA extraction the samples were 
centrifugated to 100 x g, 10 minutes 4°C, the pellet was 
resuspended in 1 PBS ml and centrifugated to 1000 x g, 
by one minute. 
Peripheral blood samples (5cc) were obtained from 
HIV+ patients, posterior to the oral clinical examination 
to determine the cell count using flow citometry and the 
viral load by RT- PCR (Amplicor HIV-1 test TM kit, 
Roche), considering a low viral load between 401-5000 
copies / mm3, moderate 5001 – 30.000 copies / mm3 
and high > 30.000 copies / mm3 
Nested PCR:
We obtained DNA from fresh biopsy samples, resus-
pended in digested buffer and proteinase K 1000 µg/
ml and 100 µl de buffer lysis (100 mM of Tris-HCl, pH 
8 and 0,1% sarcosin) were incubated overnight. Poste-
riorly, inactivation of proteinase K was done at 95° for 
5 min and followed by phenol-chloroform extraction 
and ethanol precipitation). The pellet was resuspended 
in 100 µl of TE buffer (10mM), Tris-HCl 0,1M pH 7,4; 
0,1mM EDTA pH 8,0 by 20 h at 37°C. The samples 
were kept at -20°C. 5 µl of aqueous phase were used for 
PCR. To increase the sensitivity of EBV detection, nest-
ed PCR assay were apply, using W1- W2 (W1: 5´CTA 
GGG GAG AAC GTG AA 3´) and (W2: 5´ CTG AAG 
GTG AAC CGC TTA CCA 3´) as the outer and W3- 
W4 as the inner EBV-primers (W3: 5´ GGT ATC GGG 
CCA GAG GTA AGT 3´), and (W4: 5´ GCT GGA CGA 
GGA CCC TTC TAC 3´). The inner primers amplify a 
192-bp within the sequence amplified by the outer prim-
ers. 25-µl reaction mixture consisted of 1 µM of each 
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primer, 1 µg of the extracted sample, 1 X Taq Buffer 
(100 mM Tris-HCl, pH 8.3, 500 mM KCl, 11 mM Mg-
Cl2 and 0.1% gelatin), 200 µM of each dNTPs and 1 unit 
of Taq DNA Polymerase were used. Initial denaturation 
occurred at 94°C for 4 min, followed by 30 cycles: 45s 
at 92°C, 30s at 66°C, 45s at 72°C. A final extension was 
done at 72°C for 5 min. For negative control water re-
placed the DNA target. DNA samples were reamplified 
in a nested PCR using a W3- W4 primers. We used the 
same amplification parameters for 40 cycles, using a 2 
µL template from the first step amplification products. 
Subsequently, 10 µl of the PCR reaction mixture were 
electrophoresed in a 3% agarose gel containing 0.5 µg/
mL ethidium bromide and visualized under an ultravio-
let transilluminator. A positive sample was considered 
when a 192 bp band was observed corresponded to EBV 
amplification.
Expression of EBV LMP-1 by immunohistochemistry:
The EBV (lmp-1) expression was done by immuno-
histochemistry following the standarized protocol. 3µ 
sections were obtained from each paraffin block, depar-
affinated and antigenically retrieved using tripsyn 37°C 
(30 minutes) and endogeneous peroxidase was blocked 
with methanol H202 (20 minutes).The sections were 
incubated with Anti EBV monoclonal antibody (LMP 
clone CS-1-4, Dako, USA), diluted 1:50 for 45 minutes. 
The envision detection system was used for 20 minutes 
using diaminobenzidine (DAKO) to visualize the reac-
tion and counterstained with Meyer hematoxylin.
The statistical analysis was done using the SPSS (13.0 
version) and the Chi Square non parametrical test. 
Results
Twenty-one HIV + adult patients with OHL were evalu-
ated, 20 were males (95%) and only one female (5%), 
between 21 and 60 years of age (45.5 ± 12.3). In addi-
tion, 10 patients HIV- with oral mucosal hyperkeratosis 
were studied, 6 of them were males (60%) and 4 were 
females (40%), age ranging between 21 and 70 years 
with an average (51.94 ± 16.8).
Regarding the sexual behavior in the HIV + group, there 
was a predilection in men who had sex with men 20/21 
(95%), and just one patient was heterosexual, while in 
the HIV – group all patients were heterosexual (Table 
1a, 1b)
In relation with the anatomical location and the pres-
ence of OHL, we observed 9/21 (43%) had lesions at left 
border of the tongue, 10/21 (47 %) in right lateral border 
of the tongue, 1/21 in both lateral borders of the tongue 
and buccal mucosa respectively.
In the HIV- patients with oral hyperkeratosis, we ob-
served the lesions at the buccal mucosa sulcus in 3/10 pa-
tients (30%), 1 /10 cases at right side, 4/10 (40%) in both 
sides and 2/10 (20%) at buccal mucosa and the tongue. 

Patients Gender Age (years) Sexual Behavior
Anatomical 
Location
EBV 
Detection by 
PCR
Antirretroviral 
Therapy Smoking Alcohol
1 Male 55 MSM  Left Negative No Yes Yes
2 Male 48 MSM  Right Positive Yes Yes No
3 Male 39 MSM  Left Positive Yes Yes Yes
4 Male 49 MSM  Left Negative Yes Yes No
5 Male 44 MSM  Right Positive No Yes No
6 Female 42 Heterosexual  Right Positive Yes No No
7 Male 40 MSM  Left Positive No No No
8 Male 42 MSM  Left Positive Yes No No
9 Male 57 MSM  Left Positive Yes Yes No
10 Male 36 MSM Both Positive No Yes Yes
11 Male 60 MSM  Right Negative No Yes No
12 Male 47 MSM  Right Negative Yes No No
13 Male 30 MSM  Right Positive No No No
14 Male 21 MSM  Right Positive No Yes Yes
15 Male 29 MSM  Right Positive No No No
16 Male 32 MSM  Left Negative Yes Yes Yes
17 Male 44 MSM  Right Positive Yes No No
18 Male 26 MSM Oral Mucosa Positive No No No
19 Male 40 MSM  Right Positive Yes Yes Yes
20 Male 42 MSM  Left Positive No No No
21 Male 35 MSM  Left Positive Yes No No
Table 1a. Demographic distribution of HIV (+) patients with oral hairy leukoplakia (OHL). 
PCR: Polymerase Chain Reaction EBV: Epstein Barr Virus.
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The clinical diagnosis of OHL in HIV+was confirmed 
by histopathology observing marked parakeratosis, cor-
rugated lining epithelium, acanthosis and the spinous 
cells with a clear cytoplasm and ballooning (Fig. 1).
In the HIV–group with hyperatotic lesions, only one 
case presented orthokeratosis, acanthosis and Severe 
epithelial dysplasia, one was diagnosed as oral lichen 
planus and eight were orthokeratosis, parakeratosis and 
acanthosis compatible with frictional keratosis.
The EBV genome was detected in 16/21 (76%) of the 
HIV+ patients with OHL and in 5/10 (50%) of the HIV- 
patients with hyperkeratotic lesions. Statistical signifi-
cant differences were noted in both groups (p<0.05).
 Regarding the antiretroviral therapy, 8/21 (38%) of the 
EBV+ patients were under treatment, similar number 
(38%) were EBV+ without therapy, while in the EBV- 
cases, 2/21 were not under therapy and 3/21 were under 
treatment. 
Related to the habits, 11/21 EBV + patients were to-
bacco users and 10/21 were non smokers, however in 
the EBV- /HIV- 8/10 (80%) were smokers and 2/10 (2%) 
were non smokers. These results were statistical signifi-
cant (p<0.05). In addition, the HIV+ patients 6/21 (29%) 
were alcohol users and 15/21 (71%) were non consu-
mers, while in the HIV- patients, 4/10 (40%) consumed 
alcohol and 6/10 (60%) were not. 
Regarding the presence of OHL /VEB + patients, 
we found 14/21 (66%) of them presented a viral load 
<400.000 copies RNA / ml while only 2/21 (10%) pre-
sented high viral load >400.000 copies RNA /ml. The 
EBV-/OHL patients, 5/21 (24%) had low viral load.
According to CD4+ T cell count in OHL/EBV+, we evi-
denced that 5/21 (24%) had a cell count between 100-
300 cells/ mm3, 4/21 (19%) 301-500 cells/ mm3, 4/21 
(19%) 501-700 cells/ mm3 and 3/21 701-900 cells/ mm3. 
When analyzing the OHL / EBV- cases, we determined 
that 3/21 (14%) had a CD4+ T cell count ranging from 
100-300 cells/ mm3 and 1/21 (5%) presented 301-500 
and other 500-701 cells/ mm3.
The EBV lmp-1 expression demonstrated nuclear posi-
tivity in 13/ 21 (62%) of the cases. The immunoloca-
lization was in the keratinocytes in 2/13 (15%) and in 
11/13 (84.6%) in the basal cell layer. Additionally, 4/13 
evidenced immunopositivity in the spinous cell layer. 
The intensity of the immunoreaction was low in 14%, 
moderate in 29% and strong in 19% of the cases (Fig. 2). 
The extension of the immunostaining was 30-60 posi-
tive cells (19%) and 60-100 (33%) of the cases. 
PCR: Polymerase Chain Reaction EBV: Epstein Barr Virus.
Table 1b. Demographic distribution of HIV (-) patients with hyperkeratotic oral lesiones.

Patients Gender Age (years) Sexual 
Behavior
Anatomical 
Location
EBV 
detection by 
PCR
Smoking Alcohol
1 Female 70 Heterosexual Right Border Positive Yes Yes
2 Male 45 Heterosexual Both Negative Yes Yes
3 Male 32 Heterosexual Left Border Negative Yes Yes
4 Female 55 Heterosexual Both Negative No No
5 Female 49 Heterosexual Both Positive Yes No
6
Male
53
Heterosexual
Mucosa and 
Tongue
Negative Yes No
7
Male
64
Heterosexual
Mucosa and 
Tongue
Negative Yes No
8 Male 56 Heterosexual Both Positive Yes Yes
9 Female 21 Heterosexual Left Border Positive No No
10 Male 27 Heterosexual Left Border Positive Yes No
Fig. 1. Histopatologic aspect of oral hairy leukoplakia in 
HIV+ patients. HE X40.
Fig. 2. EBV latent membrane protein -1 expression in oral 
hairy leukoplakia. X40. Note the high immunoreactivity in 
basal cells.
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Discussion
OHL represents a relatively frequent condition among 
HIV+ patients associated with EBV infection. Its occur-
rence has a prognostic value, therefore it is considered 
an immunodeficiency marker especially in HIV (+) with 
10% of the individuals presenting AIDS at the moment 
of the diagnosis and 20% could developed it in the fol-
lowing eight months. 
Previous studies have documented the OHL presence in 
moderate or mild immunodeficiency as well as in im-
munocompetent, in pregnant women and in diabetes 
mellitus patients (8). Additionally a positive correlation 
exits between the OHL prevalence and decrease of the 
CD4 T cell count (12%).
In the present investigation, we detected the EBV lmp 1 
expression in OHL in a group of HIV + and HIV - ven-
ezuelan patients. 
The distribution of the studied population according to 
gender and age group demonstrated a 95% of the OHL/
HIV + corresponded to males while a 5% were females, 
between 21 and 60 years. These results are in contrast 
to other investigations (16) where females were more 
affected and in agreement with other authors reporting 
OHL was predominantly in males (17). These higher 
prevalence in males could be due to the sexual behavior, 
men who had sex with men that represents 95% in the 
present study in concordance with other reports (16). 
Regarding the distribution of OHL according to age we 
observed a similar range between HIV+ and HIV- pa-
tients.
The OHL clinical features in the present work are simi-
lar to previous reports from the literature, with white 
non removable lesions located at the lateral borders of 
the tongue, with unilateral or bilateral presentation, 
with a corrugated smooth or hairy surface. OHL usu-
ally appears in HIV+ patients with severe immunode-
ficiency (18). 
The most frequent OHL anatomical location is lateral 
borders of the tongue, however eventually could appear 
at ventral aspect of the tongue, floor of the mouth, soft 
palate and buccal mucosa (19), in agreement with the 
present study results where 5% of the evaluated patients 
presented the entity at right or left buccal mucosa. 
In the present investigation we detected a high percent-
age of EBV positive patients (76%) by nested PCR, in 
agreement with other studies demonstrating EBV in 
OHL (8). 
Several studies have indicated that OHL/EBV is deter-
mined by the expression of multiple viral genetic prod-
ucts leading to infection and subsequent cell transfor-
mation, therefore contributing to the pathogenesis. The 
OHL spinous cell layer expressed viral latent and lytic 
proteins with a critical role in the development of the 
lesion (19).
In contrast to herpesviruses where a fulminant replica-
tion occurs resulting in cellular lysis and ulcer forma-
tion, EBV/OHL may cause acanthosis probably induced 
by cellular proliferation to reassure the cell survillance 
within the lesion. These transforming proteins origi-
nated an optimal environment for viral replication and 
the subsequent cell infection (19). Recently, Bagan et al. 
(20) reported the EBV infection in oral squamous cell 
carcinoma and verrucous proliferative leukoplakia.
The molecular diagnosis using nested PCR is of highly 
sensitivity and specificity to detect low number of viral 
particles, that probably is the existent condition in this 
disease. 
According to antiretroviral therapy in HIV+ patients, 
some authors have reported that it could not influence 
the disappareance of the disease (11), concordant with 
the present investigation results with a 38 % of the EBV 
positive patients under therapy. It is noteworthy that 
these patients were under simple antiretroviral treat-
ment and a 38% were not under therapy indicating that 
the treatment did not influence the appearance of the 
lesion. 
In the present study, there was not association between 
tobacco use and the presence of OHL. However, there 
are studies indicating a positive relation among smokers 
and OHL (2). On the other hand, in the case of HIV-, the 
majority were smokers. Alcohol use was not associated 
to OHL in the present investigation.
In relation to viral load and EBV, our results demon-
strated that a 66% of the EBV + individuals have a low 
viral load and 24% of EBV- presented a high viral load, 
concluding that there was not relation between viral 
load of the patient and EBV infection. Similar results 
were observed with the CD4+ T cell count in the HIV+/
OHL, where no association was observed. 
The EBV lmp 1 in HIV+/EBV+ /OHL patients was 
highly expressed (84.6 %) especially at the basal cells. 
In a preliminary study conducted in Venezuela, EBV 
lmp1 was detected in all HIV+ patients with the diagno-
sis of diffuse lymphocytic infiltrative syndrome (DILS) 
in minor salivary glands (10) where EBV positivity was 
marked in contrast to cytomegalovirus expression. The 
differences of the lmp 1 expression in both studies could 
be due to the viral replication localization. In OHl it was 
observed at the epithelial basal cell while in the DILS 
was prominent at ductal epithelial cells. 
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